Klotho Neurosciences, Inc.
KLTO
$0.1748
-$0.0069-3.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.15M | -4.21M | -1.39M | -1.21M | -707.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.05M | 2.14M | 327.30K | 287.30K | 0.00 |
| Change in Net Operating Assets | 150.60K | -131.30K | -43.80K | 612.80K | 260.60K |
| Cash from Operations | -2.95M | -2.20M | -1.11M | -307.00K | -446.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.50K | -23.30K | -79.60K | -89.60K | 23.90K |
| Cash from Investing | -123.50K | -23.30K | -79.60K | -89.60K | 23.90K |
| Total Debt Issued | 2.30M | 1.10M | 950.00K | -- | -- |
| Total Debt Repaid | -120.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 175.00K | 275.00K | 275.00K | 150.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 125.00K | 125.00K | 125.00K | 125.00K | -- |
| Repurchase of Preferred Stock | -125.00K | -125.00K | -125.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 778.90K | 898.90K | 770.40K | 0.00 | 250.00K |
| Cash from Financing | 3.13M | 2.27M | 2.00M | 275.00K | 350.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.90K | 48.80K | 804.90K | -121.60K | -73.00K |